TINA GREGG: Open Payments
NPI 1649463050 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,126 in 62 payments from 14 companies in 2025. Trend: 2023 $1,273 · 2024 $5,481 · 2025 $12,126
Speaker / faculty: $5,805Travel & lodging: $2,715Food & beverage: $2,121Consulting: $1,485
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 35 | $11,122 |
| ABBVIE INC. | 3 | $255 |
| Ipsen Biopharmaceuticals, Inc | 6 | $179 |
| Janssen Biotech, Inc. | 2 | $148 |
| Novo Nordisk Inc | 2 | $94 |
| Phathom Pharmaceuticals, Inc. | 3 | $66 |
| Fujifilm Healthcare Americas Corporation | 1 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
Products named: REZDIFFRA, IQIRVO, TREMFYA, RINVOQ, Wegovy, VOQUEZNA, UTASWAKO AFP-L3, DUPIXENT.
Industry payments across MS — which companies pay providers there.
